Literature DB >> 1975825

Induction of graft versus host-associated immunodeficiency by CD4+ T cell clones.

M Tary-Lehmann1, A G Rolink, P V Lehmann, Z A Nagy, U Hurtenbach.   

Abstract

Previous studies have shown that the injection of parental T cells into MHC class II mismatched F1 recipient mice can lead to graft-vs-host (GvH) reaction that manifests itself by multiple symptoms. The objective of our study was to analyze GvH reactivity induced by a single T cell clone specific for host I-A or I-E alloantigen. The T cell clones tested for GvH potential were CD4+, with or without cytolytic activity in vitro and with a lymphokine pattern that classifies them as Th1 cells. The inoculation of a single T cell clone induced a severe, but transient immunodeficiency in the host that was independent of its cytolytic activity, as demonstrated by the failure to generate a CTL response to third party allogeneic cells in vitro. Induction of immunodeficiency in the recipients required preactivation of the clones in vitro by rIl-2 and the presence of the stimulator class II alloantigen in the host. Spleen cells from these mice lacked suppressor cells, they were deficient in Il-2 secretion and exhibited a decrease in the number of CD4+ T cells. In addition, I-E expression was reduced, however, without any changes in the macrophage population and an increase in surface Ig and the B cell marker B220. Simultaneous to the immunodeficiency, the clone-injected mice produced elevated antibody titers to ssDNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Induction of T helper cell subsets.

Authors:  M Röcken; K M Müller; C Hauser
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.

Authors:  K S Slobod; E Benaim; L Woodruff; S Nooner; J Houston; M Holladay; T Lockey; J L Hurwitz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.

Authors:  Joseph H Chewning; Weiwei Zhang; David A Randolph; C Scott Swindle; Trenton R Schoeb; Casey T Weaver
Journal:  Biol Blood Marrow Transplant       Date:  2013-03-21       Impact factor: 5.742

5.  Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones.

Authors:  P V Lehmann; K Drexler; M Tary-Lehmann; F Falcioni; U Hurtenbach; Z A Nagy
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

6.  Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.

Authors:  M Tary-Lehmann; P V Lehmann; D Schols; M G Roncarolo; A Saxon
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

7.  Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.

Authors:  M Tary-Lehmann; A Saxon
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.